Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: Implications for neuropsychiatric diseases
Hong Lin, Fu‐Chun Hsu, Bailey Baumann, et al.
Neurobiology of Disease (2013) Vol. 63, pp. 129-140
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
Tanya L. Wallace, Daniel Bertrand
International review of neurobiology (2015), pp. 79-111
Closed Access | Times Cited: 34
Neonicotinoid Insecticides Alter the Gene Expression Profile of Neuron-Enriched Cultures from Neonatal Rat Cerebellum
Junko Kimura‐Kuroda, Yasumasa Nishito, Hiroko Yanagisawa, et al.
International Journal of Environmental Research and Public Health (2016) Vol. 13, Iss. 10, pp. 987-987
Open Access | Times Cited: 33
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis, Sarah A. Vunck, Valentina Valentini, et al.
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1723-1735
Open Access | Times Cited: 29
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders
Michael Y. Bai, David B. Lovejoy, Gilles J. Guillemin, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 1-2, pp. 19-33
Open Access | Times Cited: 26
Nicotinic acetylcholine receptors in the brain
Francisco J. Barrantes
Handbook of clinical neurology (2025), pp. 37-54
Closed Access
Nicotinic acetylcholine receptor subunit α7-knockout mice exhibit degraded auditory temporal processing
Richard A. Felix, Vicente A. Chavez, Dyana M. Novicio, et al.
Journal of Neurophysiology (2019) Vol. 122, Iss. 2, pp. 451-465
Open Access | Times Cited: 29
Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology
Andrea Becchetti, Laura Clara Grandi, Giulia Colombo, et al.
Brain Sciences (2020) Vol. 10, Iss. 12, pp. 907-907
Open Access | Times Cited: 24
Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
Ana Sofía Vallés, Francisco J. Barrantes
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 23
The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome
Stephen I. Deutsch, Jessica A. Burket, Maria R. Urbano, et al.
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 363-377
Closed Access | Times Cited: 28
Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding
Michelle Pershing, David Phenis, Valentina Valentini, et al.
Psychopharmacology (2016) Vol. 233, Iss. 21-22, pp. 3725-3735
Open Access | Times Cited: 27
Early VGLUT1-specific parallel fiber synaptic deficits and dysregulated cerebellar circuit in the KIKO mouse model of Friedreich ataxia
Hong Lin, Jordi Magrané, Elisia Clark, et al.
Disease Models & Mechanisms (2017) Vol. 10, Iss. 12, pp. 1529-1538
Open Access | Times Cited: 27
The role of nicotinic receptors in shaping and functioning of the glutamatergic system: A window into cognitive pathology
Susanna Molas, Mara Dierssen
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 315-325
Closed Access | Times Cited: 24
Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease
Xiao‐Hua Zhang, Kejing Lao, Zhongying Qiu, et al.
Journal of Alzheimer s Disease (2019) Vol. 67, Iss. 4, pp. 1109-1122
Closed Access | Times Cited: 21
Functional NMDA receptors are expressed by human pulmonary artery smooth muscle cells
Yi Dong, Fu‐Chun Hsu, Cynthia Koziol‐White, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia
Daniel C. Javitt
Current Treatment Options in Psychiatry (2014) Vol. 1, Iss. 2, pp. 107-120
Open Access | Times Cited: 21
Differential Modulation of GABAA and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
Xujiao Zhou, Yuan Zong, Rong Zhang, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 20
Regional Differences and Similarities in the Brain Transcriptome for Mice Selected for Ethanol Preference From HS-CC Founders
Alexandre M. Colville, Ovidiu D. Iancu, Denesa Lockwood, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 20
Integrative Pharmacology in the Treatment of Substance Use Disorders
Jack Donlon, Pooja Kumari, Sajoy P. Varghese, et al.
Journal of Dual Diagnosis (2023) Vol. 20, Iss. 2, pp. 132-177
Closed Access | Times Cited: 6
Analysis of Synapses in Cerebral Organoids
Abraam M. Yakoub, Mark Sadek
Cell Transplantation (2019) Vol. 28, Iss. 9-10, pp. 1173-1182
Open Access | Times Cited: 16
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Maju Mathew Koola
Human Psychopharmacology Clinical and Experimental (2020) Vol. 36, Iss. 1, pp. 1-16
Closed Access | Times Cited: 15
Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
Elizabeth Mercado‐Ayón, Nathan Warren, Sarah Halawani, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 8
Molecular, physiological and behavioral characterization of the heterozygous Df[h15q13]/+ mouse model associated with the human 15q13.3 microdeletion syndrome
Katherine A. Rees, Amal Halawa, Daisy Consuegra‐García, et al.
Brain Research (2020) Vol. 1746, pp. 147024-147024
Closed Access | Times Cited: 10
Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia
Ariel A. Jacobi, Sarah Halawani, David R. Lynch, et al.
Neuroscience Letters (2018) Vol. 692, pp. 107-114
Open Access | Times Cited: 9
Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
Agnieszka Jankowska, Grzegorz Satała, Anna Partyka, et al.
Current Medicinal Chemistry (2019) Vol. 26, Iss. 25, pp. 4885-4913
Closed Access | Times Cited: 9
Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice
Susanna Molas, Thomas Gener, J. Guell, et al.
Acta Neuropathologica Communications (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 7

Scroll to top